Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
53.61
-2.19 (-3.92%)
Nov 10, 2026, 11:34 AM EST - Market open
Genmab Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $70 | Buy | Reiterates | $70 | +30.57% | Nov 6, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $67 | Buy | Maintains | $67 | +24.98% | Nov 6, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $57 | Hold | Maintains | $57 | +6.32% | Nov 6, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $58 → $80 | Buy | Maintains | $58 → $80 | +49.23% | Oct 30, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $34 → $62 | Buy | Maintains | $34 → $62 | +15.65% | Oct 29, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 29, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $60 → $65 | Buy | Reiterates | $60 → $65 | +21.25% | Oct 28, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.